STRO

Sutro Biopharma Inc.

Price

$21.91

return (12m)

154.24%

p/e

-1.95

p/bv

-3.40

DIVIDEND YIELD

0.00%

STRO price

Sutro Biopharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment STRO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-4.80%

3 months

-28.45%

1 year

154.24%

2 years

-52.37%

5 years

-88.56%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals STRO

Valuation

P/E

-1.95

Sector -4.38

Industry -4.38

P/BV

-3.40

Sector 2.02

Industry 2.02

P/Revenue (PSR)

7.70

Sector -4.40

Industry -4.40

EV/EBITDA

-6.97

Sector -263.09

Industry -263.09

EV/EBIT

-6.65

Sector -702.90

Industry -702.90

P/EBITDA

-2.64

Sector -4.39

Industry -4.39

P/EBIT

-2.53

Sector -4.73

Industry -4.73

P/Total Assets

1.81

Sector 1.49

Industry 1.49

P/Net Current Assets

-2.88

Sector -11.70

Industry -11.70

P/Working Capital

2.87

Sector -3.19

Industry -3.19

EPS

-10.63

Sector -2.14

Industry -2.14

BVPS

-6.08

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

100.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-273.37%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-286.28%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-100.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.05

Sector 0.03

Industry 0.03

Profitability

ROE

174.83%

Sector -65.14%

Industry -65.14%

ROA

-92.89%

Sector -65.53%

Industry -65.53%

ROIC

-272.23%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.32

Sector 2.90

Industry 2.90

Net Debt / EBITDA

6.11

Sector -6.07

Industry -6.07

Net Debt / EBIT

5.83

Sector -8.26

Industry -8.26

Net Debt / Equity

1.59

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

-0.53

Sector 0.41

Industry 0.41

Liabilities/Assets

1.53

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-5.88%

Sector -

Industry -

5Y Earnings CAGR

11.35%

Sector -

Industry -

Fundamentals STRO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
STRO Sutro Biopharma Inc.	$21.91	139.51%	0.00%	-1.95	-3.40	174.83%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

STRO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Sutro Biopharma

Sutro Biopharma Inc.

Average Investor10 user rating

4.0 (1 people)

United States

23 years

Founded: 2003

2018

Time since IPO - 8 years

202

Employees

Sutro Biopharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $351.73 million, with shareholders equity totaling $-103.32 million.

The company employs approximately 202 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Sutro Biopharma Inc. reported $45.70 million in revenue, generating net income of $-180.63 million.

Key financial metrics include a P/E ratio of -1.95, a price-to-book (P/B) ratio of -3.40, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker STRO.

Market cap

$351.73 million

Net worth

$-103.32 million

$-103,320,000.00

Assets

$194.46 million

$194,460,000.00

Total Shares Outstanding

17.00 million

17,000,000

Average Daily Trading Volume

$363.50 Thousand

$363,501.30

Sector

Health Care

Industry

Biotechnology

STRO

STRO revenue and profits

Financial Results STRO

DRAG THE FRAME TO SEE MORE DATA

STRO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Sutro Biopharma (STRO) today?

A cotação de Sutro Biopharma (STRO) hoje está em US$ 21.91, com uma variação de 154.24% em relação ao último ano. A cotação de Sutro Biopharma (STRO) iniciou o ano negociando na casa dos US$ 11.57 e hoje está em US$ 21.91. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Sutro Biopharma (STRO) e dados de ações do Ibovespa e mercados internacionais.

Quando Sutro Biopharma (STRO) paga dividendos?

Sutro Biopharma (STRO) não distribuiu dividendos no último ano.

Is Sutro Biopharma (STRO) a good investment?

Atualmente, Sutro Biopharma (STRO) está cotada a US$ 21.91, com um P/L de -1.95, representando um desvio de -193% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 154.24 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 154.24%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Sutro Biopharma (STRO) stock?

Investir em ações de Sutro Biopharma (STRO) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Sutro Biopharma (STRO) yield today?

A rentabilidade de Sutro Biopharma (STRO) foi de -4.80% no último mês, 154.24% no último ano e -88.56% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Sutro Biopharma (STRO) hoje, o investimento total seria de US$ 2,191.00, com base na cotação atual de US$ 21.91.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 5,570.40
Em 5 anos: US$ 250.65
Em 10 anos: US$ 2,191.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

STRO

Sutro Biopharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment STRO

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING STRO WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Sutro Biopharma

Sutro Biopharma Inc.

United States

23 years

2018

202

PROFIT X PRICE STRO

Financial Results STRO

STRO cash flow

Asset, Revenue and Profit Growth - STRO

STRO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions